The TACTT team focuses on developing novel, targeted anticancer strategies that specifically eliminate tumor cells and mostly leave normal, healthy cells alone. Targeted therapy is a cancer treatment that uses drugs to target specific genes and proteins that are involved in the growth and survival of cancer cells. We are convinced that precision medicine using rationally-designed combinations of such targeted therapies may achieve this much-needed progress in cancer treatment. Moreover, we focus on oxygen deficiency (hypoxia) as a common characteristic of human solid tumours contributing to therapy resistance.
Team Leader
Associated promotors (alphabetically)
Prof. Dr. Christophe Deben
Prof. em. Dr. Martin Lammens
Prof. Dr. Filip Lardon
Prof. Dr. Pierre Montay-Gruel
Prof. em. Dr. Patrick Pauwels
Prof. Dr. Marc Peeters
Prof. Dr. Evelien Smits
Prof. em. Dr. Jan B. Vermorken
Postdoctoral researchers
Dr. Jorrit De Waele
Dr. Hannah Zaryouh
PhD students
Julie De Beukelaar
Jöran Melis
Jasper Verswyvel
ATP
Louize Brants
Christophe Hermans
Hilde Lambrechts
Ho Wa Lau
Dana Liu
Céline Merlin